相关实验视频

Updated: Sep 16, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.7K

针对晚期前列腺癌的个性化手术:通过PTEN,AR-V7,TP53,TMPRSS2-ERG和ERBB2遗传变异进行分层

Cristina Anita Ionescu, Georgeta Camelia Cozaru, Mariana Aşchie

    Chirurgia (Bucharest, Romania : 1990)
    |July 10, 2025
    PubMed
    概括

    在晚期前列腺癌中,PTEN损失和AR-V7表达等分子变化可以预测侵袭性疾病. 识别这些生物标志物有助于个性化治疗和风险分层,以获得更好的患者结果.

    关键词:
    生物标志物 生物标志物遗传特征 遗传特征 遗传特征个性化手术 个性化手术预后 预后 预后前列腺癌是前列腺癌.

    更多相关视频

    Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking07:34

    Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

    Published on: November 17, 2023

    791
    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence08:05

    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

    Published on: June 10, 2025

    674

    相关概念视频

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    5.1K